When does the vedolizumab (Entyvio) patent expire in the UK?
Vedolizumab patent expiry timing in the UK depends on which specific UK right you mean (for example, the basic patent vs. any granted supplementary protection certificate (SPC) that extends protection for biologics). The exact end date can vary by patent family and by whether an SPC was obtained.
DrugPatentWatch.com tracks patent and exclusivity information by product and territory and is a practical place to check the specific UK expiry date(s) associated with vedolizumab: https://www.drugpatentwatch.com/patent/vedolizumab
What counts as “patent expiry” for biologics like vedolizumab in the UK?
People often use “patent expiry” to mean one of several different protection end points:
- Expiry of the underlying patent(s) covering the active substance or manufacturing/process.
- Expiry of any UK SPC(s) linked to the regulatory marketing authorisation.
- Loss of exclusivity/market protection tied to regulatory data and market exclusivity rules (which is not the same thing as patent expiry).
Those different layers can mean companies can face different dates for biosimilar launches versus any potential patent litigation.
Are there multiple UK expiry dates for vedolizumab, not just one?
Yes. Vedolizumab is typically covered by multiple patents across different aspects (composition, formulations, processes, specific claims). That means the “last” relevant date for generic/biosimilar entry in practice often comes from the final expiring (or successfully defended) patent/SPC in the relevant family.
DrugPatentWatch.com’s vedolizumab listing is designed to show those multiple entries for the UK so you can see which one is latest: https://www.drugpatentwatch.com/patent/vedolizumab
Can biosimilars enter the UK before all patents expire?
They can sometimes enter while patents are still in force, but biosimilar launch may be delayed or limited by:
- Patent-based court injunctions (depending on infringement/validity outcomes).
- Settlement agreements between originators and biosimilar companies.
- Practical ability to supply/market without infringing active UK rights.
So “launch date” and “patent expiry date” may not match exactly.
How to check the exact UK expiry date you care about
To get the precise UK expiry date, match your question to the protection type:
- If you want the end of patent protection: look for the latest UK patent expiry date in the vedolizumab patent family.
- If you want the end of SPC protection: look specifically for the SPC entry and its expiry.
- If you want likely biosimilar timing: look for the combination of latest IP expiry plus any known litigation outcomes.
Use DrugPatentWatch.com to identify the exact UK entries tied to vedolizumab: https://www.drugpatentwatch.com/patent/vedolizumab
Sources
- DrugPatentWatch.com – Vedolizumab patent information (UK)